{"id":"W2610283012","doi":"10.1186/s13058-017-0836-3","title":"A phase-I study of lapatinib in combination with foretinib, a c-MET, AXL and vascular endothelial growth factor receptor inhibitor, in human epidermal growth factor receptor 2 (HER-2)-positive metastatic breast cancer","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research","topic":"Liver physiology and pathology","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; University Health Network; McGill University; Jewish General Hospital; Queen's University; Cancer Care Ontario; Princess Margaret Cancer Centre; Ottawa Hospital; Kingston General Hospital; Kelowna General Hospital; BC Cancer Agency","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Terry Fox Foundation; Cancer Care Ontario; GlaxoSmithKline; AstraZeneca","keywords":"Lapatinib; Medicine; Internal medicine; Tyrosine-kinase inhibitor; Metastatic breast cancer; Oncology; Pharmacology; Epidermal growth factor receptor; Cancer; Breast cancer; Trastuzumab","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008924851,0.0003508256,0.000958233,0.0004828156,0.0003639812,0.00004749676,0.0003448101,0.0001781138,0.0007747632],"category_scores_gemma":[0.0002004051,0.000280597,0.00008227885,0.0003912029,0.0008532954,0.0003935406,0.0002167211,0.001040992,0.000007213294],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003583881,"about_ca_system_score_gemma":0.0005079157,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.03107998,"about_ca_topic_score_gemma":0.004621745,"domain_scores_codex":[0.9959133,0.001202492,0.0005683146,0.0007938673,0.0007808992,0.0007411432],"domain_scores_gemma":[0.9977474,0.000378887,0.0003167978,0.0004977748,0.0008271278,0.0002319736],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.008296405,0.006620098,0.8955138,0.0004937273,0.0004785109,0.0001115984,0.01184453,0.000001089462,0.0663576,0.0002685251,0.0001090607,0.009905082],"study_design_scores_gemma":[0.03107777,0.005013522,0.9518577,0.0006652546,0.00008198918,0.00004573582,0.001549751,0.00002762699,0.00926565,0.000122428,0.0000134115,0.0002791561],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9940124,0.0001280582,0.000003793052,0.0008465059,0.0001313444,0.002380414,0.002387985,0.00002024824,0.00008926529],"genre_scores_gemma":[0.9984592,0.0001664242,0.00005825841,0.00004668648,0.000230192,0.0008318921,0.00008862632,0.00005810658,0.00006064652],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05709195,"threshold_uncertainty_score":0.9999646,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05536478638186775,"score_gpt":0.3903047996556466,"score_spread":0.3349400132737788,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}